Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience

• Main Authors: Chiara Bianchimani (Author), Daniela Dolce (Author), Claudia Centrone (Author), Silvia Campana (Author), Novella Ravenni (Author), Tommaso Orioli (Author), Erica Camera (Author), Gianfranco Mergni (Author), Cristina Fevola (Author), Paolo Bonomi (Author), Giovanni Taccetti (Author), Vito Terlizzi (Author)
• Format: Book
• Published: MDPI AG, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pancreatitis-Associated Protein (PAP)-based Cystic Fibrosis (CF) newborn bloodspot screening (NBS) protocols detect less CFTR-Related Metabolic Syndrome (CRMS)/CF Screen Positive, Inconclusive Diagnosis (CFSPID). We prospectively evaluated the impact of PAP as the second step of the CF NBS protocol,...